Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
Ian Dilley, Purdue College of Pharmacy student, said pharmacists should strive to show compassion and empathy.
The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
Ian Dilley, Purdue College of Pharmacy student, talks about the exciting passion for pharmacy among students at the 2015 APhA Annual Meeting and Exposition.
The largest and most recent analysis of digoxin has reaffirmed the drug’s association with a heightened risk of early death in patients with atrial fibrillation (AF) or congestive heart failure (CHF).
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$